Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/22660
Full metadata record
DC FieldValueLanguage
dc.contributor.authorHinde, Kenji-
dc.contributor.authorMaingard, Julian-
dc.contributor.authorHirsch, Joshua A-
dc.contributor.authorPhan, Kevin-
dc.contributor.authorAsadi, Hamed-
dc.contributor.authorChandra, Ronil V-
dc.date2020-02-18-
dc.date.accessioned2020-02-24T04:02:20Z-
dc.date.available2020-02-24T04:02:20Z-
dc.date.issued2020-04-
dc.identifier.citationRadiology 2020: 295(1): 96-103en
dc.identifier.urihttp://ahro.austin.org.au/austinjspui/handle/1/22660-
dc.description.abstractBackground Osteoporotic vertebral compression fractures (OVCFs) are prevalent, with associated morbidity and mortality. Vertebral augmentation (VA), defined as either vertebroplasty and/or balloon kyphoplasty (BKP), is a minimally invasive surgical treatment to reduce pain and further collapse and/or renew vertebral body height by introducing bone cement into fractured vertebrae. Nonsurgical management (NSM) for OVCF carries inherent risks. Purpose To summarize the literature and perform a meta-analysis on the mortality outcomes of patients with OVCF treated with VA compared with those in patients treated with NSM. Materials and Methods A single researcher performed a systematic literature review using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses, or PRISMA, guidelines. Online scientific databases were searched in April 2018 for English-language publications. Included studies investigated mortality in patients with OVCF with VA as the primary intervention and NSM as the comparator. A meta-analysis was performed for studies that reported hazard ratios (HRs) and 95% confidence intervals (CIs). HR was used as a summary statistic and was random-effect-models tested. The χ2 test was used to study heterogeneity between trials, and the I2 statistic was calculated to estimate variation across studies. Results Of the 16 included studies, eight reported mortality benefits in VA, seven reported no mortality difference, and one reported mixed results. Seven studies were included in a meta-analysis examining findings in more than 2 million patients with OVCF (VA = 382 070, NSM = 1 707 874). The pooled HR comparing VA to NSM was 0.78 (95% CI: 0.66, 0.92; P = .003), with mortality benefits across 2- and 5-year periods (HR = 0.70, 95% CI: 0.69, 0.71, P < .001; and HR = 0.79, 95% CI: 0.62, 0.9999, P = .05; respectively). Balloon kyphoplasty provided mortality benefits over vertebroplasty, with HRs of 0.77 (95% CI: 0.77, 0.78; P < .001) and 0.87 (95% CI: 0.87, 0.88; P < .001), respectively. Conclusion In a meta-analysis of more than 2 million patients, those with osteoporotic vertebral compression fractures who underwent vertebral augmentation were 22% less likely to die at up to 10 years after treatment than those who received nonsurgical treatment. © RSNA, 2020 See also the editorial by Jennings in this issue.en
dc.language.isoeng-
dc.titleMortality Outcomes of Vertebral Augmentation (Vertebroplasty and/or Balloon Kyphoplasty) for Osteoporotic Vertebral Compression Fractures: A Systematic Review and Meta-Analysis.en
dc.typeJournal Articleen
dc.identifier.journaltitleRadiologyen
dc.identifier.affiliationSchool of Medicine, Monash University, Melbourne, Australiaen
dc.identifier.affiliationStroke Division, Florey Institute of Neuroscience and Mental Health, University of Melbourne, Melbourne, Australiaen
dc.identifier.affiliationNeuroSpine Surgery Research Group, Prince of Wales Private Hospital, Sydney, Australiaen
dc.identifier.affiliationInterventional Neuroradiology Unit, Monash Imaging, Melbourne, Australiaen
dc.identifier.affiliationInterventional Neuroradiology Service, Department of Radiology, Austin Health, Heidelberg, Victoria, AustraliaInterventional Radiology Service, Department of Radiology, Austin Health, Heidelberg, Victoria, Australiaen
dc.identifier.affiliationDepartment of Radiology, Western Health, Western Hospital, Footscray, Melbourne, Victoria 3011, Australiaen
dc.identifier.affiliationSchool of Medicine-Faculty of Health, Deakin University, Warrun Ponds, Australiaen
dc.identifier.affiliationNeuroendovascular Program, Massachusetts General Hospital, Harvard Medical School, Boston, Massen
dc.identifier.affiliationRadiologyen
dc.identifier.doi10.1148/radiol.2020191294en
dc.type.contentTexten
dc.identifier.orcid0000-0003-2979-6420en
dc.identifier.orcid0000-0001-8958-2411en
dc.identifier.orcid0000-0002-9594-8798en
dc.identifier.orcid0000-0003-2475-9727en
dc.identifier.pubmedid32068503-
dc.type.austinJournal Article-
item.languageiso639-1en-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.fulltextNo Fulltext-
item.openairetypeJournal Article-
item.cerifentitytypePublications-
item.grantfulltextnone-
crisitem.author.deptRadiology-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

6
checked on Feb 2, 2023

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.